Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
Ownership | 2024-12-16 7:00 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal Participations S.a r.l. Director 10% Owner | 0 | $0 | 136,180,481 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-02 5:41 pm | N/A 2034-12-02 | LEXICON PHARMACEUTICALS INC. | LXRX | Cheung Ivan Director | 186,685 | $0 | 186,685 (Direct) | View |
Ownership | 2024-10-07 4:58 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DeFrancesco Lisa VP, IR and Corp Strategy | 0 | $0 | 378,040 (Direct) | View |
| 2024-08-12 Option Award | 2024-08-12 08:40 am | N/A 2034-08-12 | LEXICON PHARMACEUTICALS INC. | LXRX | Corrigan Brian SVP, Regulatory & QA | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2024-07-29 5:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Siren L.L.C. Invus Global Management LLC Director 10% Owner | 0 | $0 | 38,918,903 (Indirect) | View |
| 2024-07-08 Option Award | 2024-07-08 5:27 pm | N/A 2034-07-08 | LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and COO | 307,000 | $0 | 307,000 (Direct) | View |
| 2024-07-08 Option Award | 2024-07-08 5:27 pm | N/A 2034-07-08 | LEXICON PHARMACEUTICALS INC. | LXRX | Exton Michael Chief Executive Officer | 1,675,000 | $0 | 1,675,000 (Direct) | View |
| 2024-05-10 Exercise | 2024-05-14 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 58,697,022 | $0 | 176,250,306 (Indirect) | View |
| 2024-05-10 Option Award | 2024-05-14 5:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 1,150,922 | $108.5 | 176,250,306 (Indirect) | View |
| 2024-05-13 Option Award | 2024-05-13 4:05 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:04 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Sullivan Diane E. Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:03 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:03 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:02 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:01 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-05-13 Option Award | 2024-05-13 4:00 pm | N/A 2034-05-13 | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 81,716 | $0 | 81,716 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:21 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Swain Judith L Director | 8,032 | $0 | 48,364 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:20 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | SOBECKI CHRISTOPHER J Director | 8,032 | $0 | 167,055 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | LEFKOWITZ ROBERT J MD Director | 8,032 | $0 | 48,364 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | DEBBANE RAYMOND Director | 8,032 | $0 | 6,800,083 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | BARKER SAM L Director | 8,032 | $0 | 87,649 (Direct) | View |
| 2024-04-28 Exercise | 2024-04-29 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Amouyal Philippe Director | 8,032 | $0 | 248,364 (Direct) | View |
| 2024-03-13 Option Award | 2024-03-13 9:22 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Artal International S.C.A. Wittouck Amaury Artal International Management S.A. Artal Group S.A. Westend S.A. Stichting Administratiekantoor Westend Invus Public Equities L.P. Invus L.P. Invus Public Equities Advisors LLC Invus Advisors L.L.C. Director 10% Owner | 1,150,922 | $108.5 | 1,150,922 (Indirect) | View |
| 2024-02-28 Exercise | 2024-02-29 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 29,243 | $0 | 90,270 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:33 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 11,793 | $2.62 | 90,270 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:32 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO | 97,564 | $0 | 459,714 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:32 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO | 37,691 | $2.62 | 459,714 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources | 46,641 | $0 | 127,030 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:31 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources | 22,425 | $2.62 | 127,030 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:30 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 67,546 | $0 | 347,198 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:30 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 24,408 | $2.62 | 347,198 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:29 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 67,400 | $0 | 255,742 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:29 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 24,353 | $2.62 | 255,742 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:28 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 63,706 | $0 | 147,123 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:28 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 31,265 | $2.62 | 147,123 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:27 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 68,303 | $0 | 270,507 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:27 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Crum Brian T SVP, General Counsel & Secr. | 25,604 | $2.62 | 270,507 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:26 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 245,080 | $0 | 1,430,198 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:26 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 61,371 | $2.62 | 1,430,198 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:19 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Alexander Kristen VP, Finance and Accounting | 119,320 | $0 | 119,320 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:18 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | WADE JEFFREY L President and CFO | 628,640 | $0 | 628,640 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:17 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | McDermott Wendy VP, Human Resources | 313,900 | $0 | 313,900 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:16 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | MAIN ALAN J EVP, Innov & Chem Sciences | 409,460 | $0 | 409,460 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:15 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Kassler-Taub Kenneth B. SVP, Regulatory & QA | 407,620 | $0 | 407,620 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:14 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Granowitz Craig B SVP, Chief Medical Officer | 445,360 | $0 | 445,360 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:14 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | Garner Thomas SVP, Chief Commercial Officer | 454,260 | $0 | 454,260 (Direct) | View |